Ligand Reports Fourth Quarter and Full Year 2021 Financial Results
Go back to Ligand Reports Fourth Quarter and Full Year 2021 Financial Results| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 275.43 +13.26 (5.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $262.17 | 52 Week High | $139.79 | |||
| Open | $259.35 | 52 Week Low | $82.07 | |||
| Day High | $277.35 | P/E | 640.53 | |||
| Day Low | $258.00 | EPS | $0.43 | |||
| Volume | 1,770,435 | |||||
| (NASDAQ: VRNA) | Delayed: 106.91 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $106.91 | 52 Week High | $ | |||
| Open | $106.91 | 52 Week Low | $ | |||
| Day High | $106.91 | P/E | N/A | |||
| Day Low | $106.91 | EPS | $ | |||
| Volume | 17 | |||||
